Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Angiodynamics (ANGO) Accumulated Depreciation & Amortization (2016 - 2025)

Angiodynamics (ANGO) has disclosed Accumulated Depreciation & Amortization for 15 consecutive years, with -$28.5 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Accumulated Depreciation & Amortization fell 43.17% year-over-year to -$28.5 million, compared with a TTM value of -$28.5 million through May 2025, down 43.17%, and an annual FY2025 reading of -$28.5 million, down 43.17% over the prior year.
  • Accumulated Depreciation & Amortization was -$28.5 million for Q2 2025 at Angiodynamics, down from -$19.9 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $58.5 million in Q2 2023 and bottomed at -$28.5 million in Q2 2025.
  • Average Accumulated Depreciation & Amortization over 5 years is $21.2 million, with a median of $45.2 million recorded in 2021.
  • The sharpest move saw Accumulated Depreciation & Amortization increased 15.73% in 2023, then crashed 134.02% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $45.2 million in 2021, then increased by 11.99% to $50.6 million in 2022, then grew by 15.73% to $58.5 million in 2023, then plummeted by 134.02% to -$19.9 million in 2024, then crashed by 43.17% to -$28.5 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for ANGO at -$28.5 million in Q2 2025, -$19.9 million in Q2 2024, and $58.5 million in Q2 2023.